openPR Logo
Press release

Immunotherapy as a Substitute to Chemotherapy for First Line Treatment is Expected to Propel the Immunotherapy Drugs Market

07-27-2017 02:17 PM CET | Health & Medicine

Press release from: Transparency Market Research

Immunotherapy as a Substitute to Chemotherapy for First Line

Traditionally, the basis of cancer treatment is comprised of radiation therapy, surgery, and chemotherapy. Recently, many positive treatment options have emerged in the field of immuno-oncology. These next generation cancer treatment options point to the opportunity of new improved techniques of anticancer therapy. Immunotherapy is termed as a biological therapy in which the primary aim is to improve the human immunity system to fight against diseases such as cancer and infectious diseases. Immunotherapy treatment increases the overall immunity of the body and confines the growth of cancer cells. The treatment allows immune cells to kill cancer cells from the body.

Browse Market Research Report @ http://www.transparencymarketresearch.com/immunotherapy-drugs-market.html

The global immunotherapy drugs market is driven by the rising incidences of cancer. The major factor for most cancers is the rise in geriatric population, as cancer rates increase with age. According to a report from WHO in 2015, approximately 50% of people treated with cancer in the U.K. are over the age of 60. Obesity, change in lifestyle, smoking, and eating habits are other important factors which are increasing the number of cancer patients. People are favoring toward cancer treatments with lesser side effects. This factor is likely to propel the growth of the global immunotherapy drugs market in the next few years, as immunotherapy drugs are found to have lesser side effects as compared to other treatments.

Rise in opportunities in developing markets and immunotherapy as a substitute to chemotherapy for first line treatment are drivers which are expected to propel the growth of the market. In addition, quicker drug approval process and high prevalence rate of lifestyle diseases are projected to drive the market growth during the forecast period. However, high cost of immunotherapy devices, overall costly treatments, and lack of awareness about immunotherapy drugs and techniques are estimated to restrain the growth of the global immunotherapy drugs market in the near future.

The global immunotherapy drugs market is classified on the basis of type of drugs, application, end-user, and region. On the basis of type of drugs, the market is segmented into checkpoint inhibitors, adult vaccines, interleukins, monoclonal antibodies, interferons, alpha and beta, and others. The adult vaccines segment is subsegmented into therapeutic vaccines and preventive vaccines. The development of novel drugs and the entry of new molecules such as elotuzumab, obinutuzumab, zanolimumab, and onartuzumab into the market are projected to support the growth of this segment. On the basis of application, the market is classified as autoimmune and inflammatory diseases, cancer, infectious diseases, and others. The cancer segment is anticipated to hold a large part of the market share during the forecast period.

For more information on this report, fill the form @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=23771

Geographically, the global immunotherapy drugs market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the market during the forecast period due to favorable government initiatives, healthy R&D investment, personalized medicine, development of next generation sequencing, and availability of technologically advanced health care research framework. According to a report by WHO in 2016, it is anticipated that 1.75 million new cancer patients are likely to be detected in the U.S. only. Asia Pacific is estimated to register a high growth rate of the immunotherapy drugs market in the next few years due to development of health care infrastructure, high disposable income, rise in health and hygiene related awareness, large untapped market base, and economic development.

Key players operating in the global immunotherapy drugs market include GE Healthcare; Thermo Fisher Scientific Inc.; Cepheid; F. Hoffmann-La Roche Ltd; OPKO Health, Inc.; Myriad Genetics, Inc.; Agilent Technologies; Koninklijke Philips N.V; Qiagen; Illumina, Inc.; Novartis AG; Abbott; PerkinElmer, Inc.; Genomic Health, Inc.; and Sysmex Corporation.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Immunotherapy as a Substitute to Chemotherapy for First Line Treatment is Expected to Propel the Immunotherapy Drugs Market here

News-ID: 645204 • Views:

More Releases from Transparency Market Research

Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights for the USD 15.9 Bn Market 2022-2031
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f …
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and the
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And Competitors
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And …
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70359 Key Players and Market Developments Key players
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn

All 5 Releases


More Releases for Immunotherapy

Cancer Immunotherapy Drug Discovery Outsourcing Market
Cancer Immunotherapy Drug Discovery Outsourcing Market is thoroughly, accurate and comprehensively assessed in a report focusing on market dynamics, market competition, regional growth, segment analysis, and key growth strategies. Report buyers will have access to proven market figures including global market size in terms of revenue and volume. (Get 15% Discount on Buying this Report) A full report of Global Cancer Immunotherapy Drug Discovery Outsourcing Market is available at: https://www.orionmarketreports.com/cancer-immunotherapy-drug-discovery-outsourcing-market/57424/ The Cancer Immunotherapy
Immunotherapy Drugs Market
Immunotherapy drugs are used to treat cancer, infection, respiratory and autoimmune disorders. Immunotherapies either stimulate the activities done by specific components of the immune system or counteract the signals that are produced by the cancer cells and suppress the immune responses. The Immunotherapy Drugs Market accounted to USD 107 billion in 2016 growing at a CAGR of 13.2% during the forecast period of 2017 to 2024. The upcoming market report contains
Immunotherapy Drugs Market
Immunotherapy is the management of a disease by enhancing, suppressing, or inducing an immune response. Some immunotherapies are designed to magnify or elicit an immune response. They are known as activation immunotherapies. However, some immunotherapies that suppress or reduce the immune response are known as suppression immunotherapies. Cell-based immunotherapies are useful for some types of cancers. Immune effector cells includingmacrophages, dendritic cells, lymphocytes, cytotoxic T lymphocytes (CTL), natural killer cells
Cancer Immunotherapy Market Cancer Immunotherapy Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Immunotherapy: Mending Cancer Regimens 1.1 Preface to Cancer Immunotherapy 1.2 Evolution of Cancer Immunotherapy 2. Categorization of Cancer Immunotherapy 2.1 Specific Cancer Immunotherapy 2.1.1 Cancer Vaccines 2.1.2 Monoclonal Antibodies 2.2 Non-Specific Cancer Immunotherapy 2.2.1 Adoptive Cell Transfer Immunotherapy 2.2.2 Immune Checkpoint Inhibitors 3. Fundamentals
Global Cancer Immunotherapy Market & Cancer Immunotherapy Clinical Trials Outloo …
Pharmaceutical companies are actively engaged in research and development of cancer immunotherapies because of large unmet medical necessities. Investigators are trying to come forth with innovative cancer immunotherapeutic products having high safety and efficacy profiles which are not offered by conventional therapeutics. Higher investments in research and development segment could significantly increase the drug discovery rates which will alleviate the medical condition of cancer patients. Simultaneously, technological advancements are being
Cancer Immunotherapy Market: Increasing Government Support Work in Favor of Canc …
Global Cancer Immunotherapy Market: Snapshot The global cancer immunotherapy market is expected to experience a very high rate of growth over the coming years, owing to the increase in the number of patients suffering from various types of cancer. In terms of the treatment options for cancer, cancer immunotherapy is expected to make serious headway due to its proven greater efficiency over conventional treatment methods. The market is also expected to